SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Advancing blood transfusion safety using molecular detection in the country of Georgia
15 references·0 citing·43 second hop
Advancing blood transfusion safety using molecular detection in the country of Georgia (2023)Advancing blood transfusion safety using …Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 2016 (2020)Screening Blood Donors for HI…Blood transfusion safety in the country of Georgia: collateral benefit from a national hepatitis C elimination program (2020)Blood transfusion safety in t…Blood Transfusion Safety in Low-Resourced Countries: Aspiring to a Higher Standard (2020)Blood Transfusion Safety in L…Sociodemographic and behavioral characteristics associated with blood donation in the United States: a population‐based study (2019)Sociodemographic and behavior…Prevention of transfusion-transmitted infections (2019)Prevention of transfusion-tra…Blood transfusion safety in sub‐Saharan Africa: A literature review of changes and challenges in the 21st century (2018)Blood transfusion safety in s…Assessment of HIV transfusion transmission risk in South Africa: a 10‐year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes (2018)Assessment of HIV transfusion…Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa (2017)Use of Blood Donor Screening …Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia (2017)Three-Year Experience in NAT …Reduction of the risk of transfusion‐transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5‐year review (2012)Reduction of the risk of tran…Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa (2009)Impact of individual‐donation…Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey (2008)Impact of nucleic acid testin…Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Current prevalence and incide…Prevalence of hepatitis B, hepatitis C, syphilis and HIV in Georgian blood donors (2001)Prevalence of hepatitis B, he…Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV‐1 antibody screening (1991)Risk of human immunodeficienc…Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody (1988)Exposure of Patients to Human Immunodeficiency Virus through the Transfusion of Blood Components That Test Antibody-Negative (1989)Transmission of Retroviruses by Transfusion of Screened Blood in Patients Undergoing Cardiac Surgery (1989)Evaluation of Screened Blood Donations for Human Immunodeficiency Virus Type 1 Infection by Culture and DNA Amplification of Pooled Cells (1991)Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. (2002)Emerging infectious disease agents and their potential threat to transfusion safety (2009)The Risk of Transfusion-Transmitted Viral Infections (1996)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions (2009)Prevalence and prevalence trends of transfusion transmissible infections among blood donors at four chinese regional blood centers between 2000 and 2010 (2012)Nucleic acid amplification testing in Indian blood banks: A review with perspectives (2017)Safety of the Blood Supply in the United States: Opportunities and Controversies (1997)Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996 (2000)Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Effect of HIV pre‐exposure prophylaxis (PrEP) on detection of early infection and its impact on the appropriate post‐PrEP deferral period (2020)The evolving blood donor deferral policy for men who have sex with men: impact on the risk of HIV transmission by transfusion in France (2020)Robust possibilistic programming to design a closed-loop blood supply chain network considering service-level maximization and lateral resupply (2022)Maternal mortality in sub‐Saharan Africa: the contribution of ineffective blood transfusion services (2008)Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. (2009)Blood Transfusion Safety in Africa: A Literature Review of Infectious Disease and Organizational Challenges (2011)Guidance for the procurement of COVID‐19 convalescent plasma: differences between high‐ and low‐middle‐income countries (2020)Sero-prevalence of transfusion transmittable infections: HIV, Hepatitis B, C and Treponema pallidum and associated factors among blood donors in Ethiopia: A retrospective study (2020)Status of hospital-based blood transfusion services in low-income and middle-income countries: a cross-sectional international survey (2022)Changing age distribution of the blood donor population in the United States (2007)Adverse Reactions to Allogeneic Whole Blood Donation by 16- and 17-Year-Olds (2008)Continued decline in blood collection and transfusion in the U nited S tates–2015 (2017)Screening donors for COVID ‐19 convalescent plasma (2020)Lessons learned from the COVID‐19 pandemic blood supply crisis (2022)Leveraging Donor Populations to Study the Epidemiology and Pathogenesis of Transfusion-Transmitted and Emerging Infectious Diseases (2023)Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations (2011)Prevalence of human immunodeficiency virus , hepatitis B virus, and hepatitis C virus in United States blood donations, 2015 to 2019: The Transfusion‐Transmissible Infections Monitoring System ( TTIMS ) (2020)Civilian walking blood bank emergency preparedness plan (2021)HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men (2021)Barriers to Hepatitis B Vaccine Coverage among Healthcare Workers in the Republic of Georgia: An International Perspective (2009)Seroprevalence of major blood-borne infections among blood donors in Kano, Nigeria (2012)Seroprevalence of HBV, HCV, HIV and Syphilis Markers among Blood Donors at Suez Canal University Hospital Blood Bank (2014)Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms (2010)The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood (2011)Problems and Approaches for Blood Transfusion in the Developing Countries (2016)HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concern (2020)Assessing the global burden of hemorrhage: The global blood supply, deficits, and potential solutions (2021)
this work references cited by second hop

References

  • 2002Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population642 cited
  • 2019Prevention of transfusion-transmitted infections295 cited
  • 1991Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV‐1 antibody screening177 cited
  • 2009Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa139 cited
  • 2018Blood transfusion safety in sub‐Saharan Africa: A literature review of changes and challenges in the 21st century119 cited
  • 2008Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey99 cited
  • 2020Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 201678 cited
  • 2019Sociodemographic and behavioral characteristics associated with blood donation in the United States: a population‐based study60 cited
  • 2018Assessment of HIV transfusion transmission risk in South Africa: a 10‐year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes55 cited
  • 2001Prevalence of hepatitis B, hepatitis C, syphilis and HIV in Georgian blood donors54 cited
  • 2012Reduction of the risk of transfusion‐transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5‐year review39 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2017Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia30 cited
  • 2017Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa28 cited
  • 2020Blood Transfusion Safety in Low-Resourced Countries: Aspiring to a Higher Standard20 cited
  • 2020Blood transfusion safety in the country of Georgia: collateral benefit from a national hepatitis C elimination program15 cited
  • Cited by

    No citing works inside the corpus for this window.